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It has recently been shown  that  a  variety of high molecular weight poly- 
saccharides  or polysaccharide complexes combine with properdin and  inacti- 
vate C'3 in vitro,  and alter properdin levels and resistance to infection in mice 
(1-9). Lipopolysaccharides derived from Gram-negative bacteria (endotoxins) 
have been found, on a weight basis, to be the most effective of these substances 
in their ability to increase properdin levels and nonspecific resistance in mice 
(3--6).  In the preceding paper (10)  it  was shown that  certain polysaccharide 
complexes  derived  from  animal  and  plant  tissues  evoke  the  classical  host 
responses generally associated with bacterial endotoxins. The present commtmi- 
cation deals with the interaction of the properdin system with some of these 
same  tissue polysaccharides.  It is  shown  that  certain high molecular weight 
polysaccharide  complexes  derived  both  from  normal  and  neoplastic  mam- 
malian tissues combine with properdin and inactivate  C'3 in vitro,  and alter 
properdin  levels and  resistance  to  infection  in  mice,  in  a  manner similar to 
bacterial lipopolysaccharides. 
Material~ and Metkods 
Polysaccharides.--Eight  of the tissue polysaccharides, and the 2 from bacteria, described 
in the preceding paper  (10)  are dealt with in the present report. The dried materials were 
dissolved or evenly dispersed to give a  final concentration of 10 rag. per ml. in veronal buf- 
fer containing Mg  ++ and Ca  ++ (11)  for in vitro studies; saline was the diluent for the in vivo 
studies. 
In  Vitro  Interactions  with the  Human  Properdin  System.--Titers  of  properdin,  comple- 
ment, and complement components were determined as previously described (11-13). Hu- 
man serums were carefully selected to conform to the criteria established previously (11). 
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Varying amounts  of the polysaccharides were added  to  1.5  ml.  of fresh pooled human 
serum. This pool was known to yield satisfactory R3 and RP after zymosan treatment, with 
no appreciable loss in  C'I, C'2 and  C'4  (11).  The mixtures of serum and  polysaccharide, 
along with suitable controls, were incubated at 37  ° for 1 hour, with occasional mixing. They 
were then centrifuged at  35,000  g for 2  hours at 2°; this resulted in sedimentation  of the 
polysaccharide; the supernatants were carefully decanted and tested for their properdin and 
complement-component  activities. 
In  Vi~o Studies  on the Properdin  System.--Albino  mice of the NIH strain, of both sexes, 
were employed in groups of 10. Three or more groups of mice were given graded doses of 
each polysaccharide in 0.5  mi. of saline intraperitoneally. At the same time, control groups 
receiving only saline were bled for base-line properdin titers. At predetermined time inter- 
vals, the injected mice were exsanguinated  by heart  puncture under chloroform anesthesia. 
About 2 ml. of serum were obtained from each group. The pooled serums were frozen promptly 
and held at  -55°C. until assayed. Before titration, they were thawed at room temperature 
and an aliquot of each serum was centrifuged at 35,000  g for 2  hours at 2 °. The supema- 
rants and uncentrifuged aliquots were then immediately assayed under code.  All serums in a 
given experiment were titrated on the same day with the same reagents. 
AltcfoJions  in Re.~ist~nce to Infe~tion.--Increase  in non-specific  resistance was determined 
by the effect of a single graded dose of polysaccharide given intraperitoneaUy to each group 
of 10 mice at  intervals of 6 to 24 hours prior to  challenge. Unless otherwise noted,  albino 
mice  of the  NH-I strain were  employed.  The  animals were  experimentally infected with 
a saline suspension  of 5 X  107 to 1 X  l0  s organisms of a 6 hour culture of Salmonella  typhosa 
Ty2  injected  intraperitoneally;  this  represented  approximately  6  to  12  LDe's.  After  72 
hours, the mortality in the treated and untreated groups was compared. 
Infection-promoting activity was  determined  in a  manner  similar to that  described by 
Rowiey (2).  First, the virulence of F_~cher~h/~ coli 2380, the cB~llenge organism, was ascer- 
tained.  Groups of 8  mice, of both sexes,  were injected intraperitoneally with dilutions of a 
15 hour culture of E. co//suspended in 1.75 per cent hog gastric mucin  1 +0.4 per cent char- 
coal;  the  LDio  varied  from  2  X  103  to  10  X  103  organisms.  The  optimal  conditions 
for measuring infection-promoting activity of the polysaccharides were then established in 
a  series of pilot experiments. As finally adopted,  groups of mice received intraperitoneally 
or intravenously 0.5 log dilutions of polysaccharide and,  1 hour later, they were challenged 
intraperitoneally with 20 bacteria. In each experiment, as a  control on the virulence of the 
culture,  appropriate  numbers  of organisms suspended  in mucin  -[- charcoal, were injected 
into untreated mice. After 72 hours, the mortality in the treated groups was compared with 
that  in the controls. 
RESULTS 
In  Vitro Interaction  of the Properdin System  witk Mammalian  Polysaccka- 
r/des.--Human  serum  of known properdin content was  treated  with varying 
amounts of the materials  being tested,  and the ability of these substances to 
interact with properdin was determined.  The results in Table I  are expressed 
as the smallest  amounts of polysaccharide sufficing to remove 8  units of pro- 
perdin from human serum and to inactivate 240 units of C'3 under standard 
conditions.  Those  tissue  polysaccharides  found  previously  to  evoke  "endo- 
t Although  it  is recognized that there  are theoretical  objections  to  the  use  of mucin, it 
was employed here for its convenience  and because  of Rowley's  (2) reproducible data with 
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toxic" phenomena also interacted with properdin in a manner similar to bac- 
terial  polysaccharides;  those  preparations  which  possessed  no  "endotoxic" 
activity did not combine with properdin. 
It was reported earlier (1) that some bacterial polysaccharide preparations 
interacted only with  properdin,  while  others  also  inactivated  C'3.  Table I 
gives data on the inactivation of C'3  by the products under study.  All the 
"endotoxic" tissue polysaccharides interacted with properdin and inactivated 
C'3,  as do zymosans, bacterial cell walls,  and some bacterial endotoxins. On 
the  other hand,  as expected, those  substances  which  did  not  combine with 
TABLE I 
In Vitro Reaction of Polysacckaride Complexes with the Human Properdin  System 
Source of polysaccharide 
Mouse kidney  ................................ 
"  lung  .................................. 
"  liver  .................................. 
"  stomach  .............................. 
"  Sarcoma 37 ........................... 
"  Carcinoma 241-6 
Rabbit skin .........................  ......... 
Chick embryo skin ......................... 
Serratia raareescens ............................ 
Salmonella typhosa ............................ 
Amount requlred  for 
Removal or 
insctivation of 8 units 
of properdin 
rag, 
4 
5 
5 
4 
2 
4 
Negative 
Negative 
3 
2 
Inactivation of 240 
units of C'3 
rag. 
2 
2 
4 
4 
2 
3 
Negative 
Negative 
$ 
* Negative at 5 rag. Larger amounts were anficomplementary. 
properdin failed to inactivate C'3. However, the two purified bacterial prepa- 
rations employed in this study, while combining with properdin, did not in- 
activate C'3 at the highest levels which could be satisfactorily tested. 
In  Vivo  Alterations  in  Properdin  Levds.--It  has already been shown  that 
injection of bacterial lipopolysaccharides elicits in mice a  rapidly developing 
rise in their properdin levels (3). High molecular weight substances are found 
in the blood at the time that properdin levels are elevated. These substances 
interfere with the determination of properdin by the zymosan assay, but can 
be removed by centrifugafion at 35,000 g before titration. 
Table II shows that marked changes also occur in the properdin titers of 
serums from mice previously injected with varying amounts of mouse kidney 
polysaccharide. These alterations are similar to those observed following the 
administration of bacterial polysaccharide (3). It will be noted that within 6 
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fell to extremely low levels. Indeed, after the administration  of 500 ttg. the titer 
fell  to  15  per  cent  of normal.  Centrifugation  of the  serums  at  this  time  (at 
35,000 g) had no measurable effect on the properdin  titer.  Mice receiving this 
amount of polysaccharide were susceptible to infection at this time or earlier. 
Twelve hours following the injection  of tissue polysaccharides,  no significant 
change in properdin titers was observed. However, at 24 hours, elevated proper- 
din titers were found in serum samples which had been centrifuged at 35,000 g. 
The serums from animals receiving the smallest dose of polysaccharide (20 ttg.) 
yielded properdin  titers  of 48 units,  an  extremely high  value.  Such mice are 
TABLE II 
Serum Properdin Levds of Mice  following Injection of a Mouse Kidney Polysaccharid¢ 
Amount of polysaccharide 
injected  i.p. 
~g 
2O 
100 
500 
Treatment of serums prior to 
properd/n assay 
Untreated 
Centrifuged:[ 
Untreated 
Centrifuged:~ 
Untreated 
Centrffuged:~ 
Properdln titers at various times after injection 
of polysaccharide, tmil$/ml, serm,  n* 
6 hrs. 
Control (saline)  Untreated  18  18 
Centrifuged:~  18  18 
* Groups of 10 mice each were employed to obtain a serum pool for each dose-time 
~: Centrifuged at 35,000 g for 2 hours at 2  ° C. 
12 hrs.  24 hrs. 
18  18 
24  48 
18  15 
12  24 
12  12 
12  24 
18 
18 
interval. 
highly  resistant  to  infection  at  this  time.  Other  changes  are  also  apparent. 
Following  high  speed  centrifugation,  small  pellets  collect  in  the  centrifuge 
tubes containing the serums which show differences in properdin titers between 
centrifuged and uncentrifuged specimens. These pellets do not appear following 
the  centrifugation  of  serums  from  control  mice.  The  nature  of  these  high- 
molecular  weight  substances is being investigated.  Preliminary  evidence sug- 
gests that  they are similar  to the high-molecular  weight  substances found in 
serum following the administration  of endotoxins  (3). 
The results of an experiment dealing with the alterations in serum properdin 
levels by other tissue polysaccharides are given in Table III. These observations 
were subsequently extended in two ways; different dose levels and additional 
products were employed in another experiment  which is summarized  in Table 
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din alterations produced by polysaccharides of normal and neoplastic mam- 
malian tissue. With the exception of the products derived from rabbit  skin 
and chick embryo skin, which were also inactive in all other tests, the tissue 
polysaccharides produced a significant depression or elevation in the properdin 
levels of mice. As anticipated from our previous findings with bacterial poly- 
saccharides, the direction and magnitude of these alterations depended upon 
the nature of the preparation, the dose, and the timing of its administration. 
At  the  higher doses,  low initial  properdin  titers  were  observed  which  were 
TABLE III 
Serum Properdln Levels of Mice following Injection of Polysor,  charide Complexes 
Source of polysacchar/de 
Mouse kidney 
Mouse Carcinoma  241-6 
Rabbit skin 
Control (saline) 
Amount of 
pol~saccharlde 
mjected 
~g. 
soo 
100 
20 
500 
100 
20 
500 
I00 
20 
Properdin fiters at various times after injection 
of polysaecharide, unit~/ml,  serum" 
6 hrs.  12 hrs. 
3  12 
6  12 
6  24 
6  9 
6  18 
12  36 
18  18 
18  18 
18  18 
18  18 
24 hrs. 
24 
24 
48 
18 
18 
36 
18 
18 
18 
18 
* The properdin  values were obtained  on pooled serums from groups of 10 mice at each 
dose-time combination. The serums were centrifuged at 35,000 g  at  2 °  C. for 2  hours prior 
to properdin assay. 
followed by elevations well above  normal  levels.  As  had  been  reported  for 
bacterial polysaccharides (3), appropriate low dosage of these preparations did 
not produce a  reduction, but only a  rapid rise in titer. The magnitude of the 
effects of tissue polysaccharides on serum properdin titers in dvo, the evocation 
of high molecular weight substances of host origin, and the small quantities 
sufficing to produce these  effects are similar to  those produced by bacterial 
polysaccharides. 
It was pointed out previously (5) that the properdin titers of mice determined 
prior to infection with Gram-negative organisms provided an incomplete pic- 
ture of the subsequent reaction to infection. The properdin levels determined 
after challenge more accurately reflected the bacteriologic course and the out- 
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TABLE IV 
Serum Properdin Levels of Mice following Injeclion of Polysaccl~aride Complexes 
Source of polysaccharide 
Mouse kidney 
Mouse liver 
Mouse stomach 
Mouse Sarcoma 37 
Mouse Carcinoma 241-6 
SerroJia marcescens 
Salmonella typhos¢~ 
Control (saline) 
Amount  of 
polF~.,  ccharlde 
rejected 
IO0 
20 
5 
1 
I00 
20 
,5 
I 
100 
20 
5 
1 
100 
20 
5 
1 
Properdln titers at various times after  in- 
jectwn of polysaccharide. ~s/ml. serwn* 
100 
20 
5 
1 
12 hrs.  24 hrs. 
18  24 
18  18 
12  12 
6  24 
12  24 
18  24 
12  12 
3  12 
18  24 
18  18 
12  12 
6  12 
9  12 
24  24 
12  12 
18  12 
12  12 
18  3 
18  18 
24  36 
18  18 
18  30 
18  30 
12  12 
* The properdin values were obtained on pooled serums from groups of 10 mice at each 
dose-time combination. The serums were centrifuged at 35,000 g. at 2  ° C. for 2 hours prior 
to properdin assay. 
and mortality, were followed in control mice and in mice treated with a mouse 
lung polysaccharide 6 hours prior to challenge with S. typhosa.  The results of 
this experiment, given in Table V,  reveal that  in control mice given saline, 
progressive decline in properdin levels and a  high mortality occurred. In mice 
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properdin levels was evident at the time they were challenged. However, such 
animals maintained adequate properdin titers  with a high survival rate.  Mice 
given I00 pg. showed titcrs  below normal levels  at  the time of  challenge,  which 
gradually rose  to  the  normal range with  an  accompanying low  mortality. 
TABLE V 
Effect of a Mouse Lung Polysa,  charlde on Properdin Levds of Mice after Infection  with 
S. ¢yphosa 
Amount of polysaccharide 
njected i.p. 6 hrs. prior to 
challenge* 
100 
20 
4 
Control (saline) 
Properdin 
titer  st time 
of challenge 
units/ml. 
6 
12 
12 
12 
Properdin titers st various times after challenge, 
unils/ral,  serum 
3 hrs. 
6 
18 
18 
12 
6 hrs. 
6 
18 
12 
6 
12 hrs. 
6 
18 
12 
6 
18 hrs.  24 hrs. 
12  12 
18  18 
6  6 
3  3 
Survival 
p~c$nt 
9O 
8O 
50 
10 
* The challenge  dose was 5  X  107 organisms;  this represented 6  X  LD~o. Mice of the 
Bagg strain were employed in this experiment. 
TABLE VI 
Increased Resistance to Infection with S. typhosa  following Administration  of a Mouse 
Lung Polysac~harids 
Amount of l~olysscchv.fide 
injected i.p. 
50 
10 
2 
Control (saline) 
* The challenge dose was 
Resistance to infection for various intervals betweeu injection of 
polysaccharide and challenge* 
6hrs.  I  12  hrs.  I  24hm. 
Per cent survivors$ 
0 
60 
70 
0 
90 
100 
40 
0 
100 
80 
20 
0 
X  10  a organisms;  this represented 12  X  LDBo. Mice of the 
Rockland strain (males) were employed in this experiment. 
Each value represents a group of 10 mice. 
Alterations in Resistance to Infection.--The pattern of the effect on resistance 
following the administration of polysaccharide is manifest within the first 24 
hours  (5).  Consequently,  in setting up time-dose experiments (each involving 
more than 1000 mice), it was desirable to compare all the tissue polysaccharides 
in  one  experiment,  rather  than  to  undertake  a  number  of  smaller different 
experiments to obtain data beyond the 24 hour interval. Protection was readily 
demonstrable with most of the tissue polysaccharides, although there were some 
variations in  the degree of protection similar to  those observed in the earlier 106  PROPERDIN  SYSTEM  AND  IMMUNITY.  VII 
experiments with bacterial polysaccharides (5). The data obtained with all the 
tissue  and bacterial polysaccharides studied  are  too voluminous and  complex 
to  be  presented  in  their  entirety.  For  this  reason,  the  induced  resistance  to 
infection is detailed for only one typical product; v/z., mouse lung polysaccharide 
(see Table VI). Increased resistance  to infection was observed within  6  hours 
after a  single dose of a  few micrograms of this polysaccharide. However, with 
TABLE VII 
Alteration  in  Resistance  to  Infection  Following  Administration  of Polysacckaride  Complexes 
Source of polysaccharide 
Mouse kidney ........................... 
"  lung ............................. 
"  liver .............................. 
"  stomach .......................... 
"  Sarcoma 27 ....................... 
"  Carcinoma 241-6  .................. 
Rabbit skin .............................. 
Chick embryo skin ...................... 
Serraga marcescens ........................ 
Salmonella  typhosa ........................ 
Amount of polysaccharlde required to 
Protect $0 ~r  cent of mice 
against a  lethal challenge* 
6-24 hr~ after In|. of 
polytmccharlde 
(increased ~ost reslsta~e) 
l.tt. 
4 
4 
20 
20 
4 
2O 
Inactive 
Inactive 
1 
1 
Kill 50 per cent of mlce 
with a nonlethal challenges 
I hr.af~rinJ,  of 
polysaccharide 
(increased ko  st 
susceptibility) 
/zg. 
3OO 
30 
30 
3O 
30 
3OO 
Inactive 
Inactive 
3O0 
10 
* 5 X  l0  T  S. typhosa  Ty2 suspended in saline; this represented approximately  6 ×  LDs0. 
Control mice received 0.5 ml. saline 6,  12, or 24 hours prior to challenge; there were no sur- 
vivors. 
2 X  101 E. coli 2380 suspended in 1.75 per cent mucin plus 0.4 percent charcoal; none of 
the control mice was killed with this dose.  (The LD60  was 2 X  10  ~ organisms.) 
this  small  dose,  the  effect  was of short  duration.  On  the  other hand,  the  in- 
jection of larger amounts  (50 #g.) resulted in absence of resistance at 6 hours, 
followed by a  high  level of protection at  12 hours which persisted  at  least  24 
hours. 
Similar alterations in resistance were induced by all the tissue polysaccharides 
except  those from rabbit  skin and  chick embryo skin.  In each  case, the dose 
was determined which protected 50 per cent of the mice against a  lethal chal- 
lence of S.  typhosa.  These  data  are  summarized  in Table VII, column 2. The 
amounts of the tissue polysaccharides required for such protection were similar 
to a variety of bacterial polysaccharides. It is noteworthy that the activities of 
3 of the 6 active tissue preparations listed  in Table VII approached those  of 2 
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It is known that the same bacterial polysaccharides which increase resistance 
to infection  are  also capable,  under  different conditions,  of depressing host 
resistance. Data on the infection-promoting action of the tissue polysaccharides 
are also presented in Table VII for contrast with their protective effect. The 
challenge  organism, E. coli 2380, administered in mucin +  charcoal was em- 
ployed in the infection-promoting studies (2). The LD60 dose was 2,000 to 3,000 
organisms.  More than  1,000 organisms were required to produce fatalities in 
even a small proportion of the control animals.  On the other hand, 20 organisms 
sufficed  to kill a  high proportion of mice pretreated with active tissue poly- 
saccharides 1 hour before challenge.  In one experiment, as few as 3 organisms 
proved lethal for some of the polysaccharide-treated mice. In still another test, 
some  of  these  polysaccharides  were  administered  intravenously  and,  here 
again, a challenge  of 20 organisms proved fatal to many of the animals,  indi- 
cating that the effect they produced was extraperitoneal in nature. Thus, this 
activity of tissue polysaccharides paralleled  their  other biologic  activities in 
their interaction with the properdin system. 
DISCUSSION 
The foregoing results show that polysaccharide complexes derived from both 
normal  and neoplastic mammalian  tissues may combine with properdin,  in- 
activate C'3 in mtro, and alter the properdin levels and non-specific resistance 
of mice.  In the preceding report (I0) it was shown that certain of these poly- 
saccharides evoked the  host responses elicited by bacterial  endotoxins.  The 
data in the present paper extend this parallelism: those tissue polysaccharides 
which exhibited "endotoxic" activity also interacted with the properdin system 
in vitro  ~ and were effective in elevating or depressing properdin levels in mice. 
However, it should be pointed out that some zymosans, dextrans, and levans 
possessing  little  or no  "endotoxic"  properties  nonetheless  interact  with  the 
properdin system Cn dlro and alter properdin levels in d~o. Thus, endotoxic ac- 
tivity and properdin interaction are not necessarily associated properties. The 
tissue polysaccharides possess both of these properties; moreover they bear a 
further resemblance to the bacterial products in that small amounts suffice to 
increase properdin levels and raise non-specific resistance in mice. Furthermore, 
like the bacterial polysaccharides, these tissue products evoke the appearance 
in the blood of high molecular weight substances which interfere with the assay 
of properdin. 
The non-specific  nature of the increased resistance to infection induced by 
these substances is obvious from several types of observations. First, the elici- 
tation of this effect with bacterial polysaccharides unrelated  to the challenge 
organism makes clear that it is independent of the classical immune mechanism 
It  has  been  shown  recently that  substances  which  inactivate properdin  in  vitro  (14) 
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(antigen-antibody  reactions).  Second,  agents  obtained  from  non-microbial 
sources produce effects similar  to those of the bacterial.  Third, polysaccharide 
complexes  derived from mouse tissues cause marked changes in the defensive 
capabilities and in the properdin levels of the identical species, the mouse, from 
which they were obtained. This further minimizes  the possibility of the inter- 
vention of specific immunologic mechanisms and  thereby reinforces  the con- 
cept of the non-specific  nature of this type of protection. 
The  finding  that  polysaccharide  complexes  from  normal  and  neoplastic 
tissues  combine  with  properdin  and,  in  large  amounts,  depress  properdin 
titers and resistance to infection,  as do polysaccharides of microbial origin, may 
help to explain the low properdin titers found in' irradiation illness,  shock, or 
advanced neoplastic disease (] 5-19). It has already been shown that following 
whole body radiation  (18) or irreversible  hemorrhagic shock (19) there occurs 
an early and rapid fall in properdin levels, accompanied by loss of resistance to 
infection and to endotoxins (17, 18). These effects have been considered  to be 
related to invasion by bacteria or their products, inasmuch as low properdin 
values are found in infection with Gram-negative organisms  (5). However, the 
data presented here suggest an alternative explanation for the low properdin 
titers that occur in some pathologic states other than infection; i. e., the liber- 
ation of endogenous polysaccharide complexes from the host tissues themselves 
(9,  20).  It  is  conceivable  (10)  that  such liberation  of polysaccharides could 
occur following  tissue breakdown from a  variety of causes such  as trauma, 
anoxia or, indeed, by the action of microbial polysaccharides or of those pre- 
viously liberated from tissues. It is thus visualized that the reactions of the host 
in certain infections and in other pathologic states may be influenced by endog- 
enous substances, such as these high molecular weight polysaccharides. 
Some of the physiological  disturbances elicited by relatively large  amounts 
of tissue polysaccharides can be considered  injurious  to the  host.  However, 
their liberation in small amounts may actually be advantageous in the main- 
tenance or even in the elevation of properdin levels. Such an effect would con- 
stitute a contribution toward the maintenance of natural resistance.  Further- 
more, evidence has been obtained that properdin inactivates bacterial pyrogens 
(21) and a "toxic factor," which destroys leucocytes, shown (17) to be present 
in the blood of animals in irreversible  shock. These findings suggest that under 
certain conditions properdin may function in the control of endotoxic substances 
of tissue origin,  such as the preparations  employed in the present study. The 
knowledge that  polysaccharides derived from  tissues,  as  well  as  those from 
bacteria,  can interact  with properdin  widens the  scope of the part  that  the 
properdin system may play in host defensive mechanisms. 
SUMMARY 
High molecular weight polysaccharide complexes  derived from normal and 
neoplastic mammalian  tissues were found to combine with properdin and  to L. PILLEMIER,  M. LANDY~  AND  M. ]. SHEAR  109 
inactivate C'3 in vitro. These polysaccharide preparations were also found to 
alter properdin levels and non-specific resistance to Gram-negative infection in 
mice. In  these manifestations, the  tissue polysaccharides bore  a  marked re- 
semblance to bacterial lipopolysaccharides. 
Some implications of the interactions of tissue polysaccharides and properdin 
in certain disease states are considered. 
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